Loading clinical trials...
Loading clinical trials...
Phase III,Randomized Controlled Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
Conditions
Interventions
Rituximab
Gemcitabine
+5 more
Locations
6
China
Tongji Medical College of HUST
Wuhan, Hubei, China
The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital)
Nanjing, Jiangsu, China
QiLu Hospital of Shandong University
Jinan, Shandong, China
Shandong Province Hospital
Jinan, Shandong, China
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Sudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Start Date
May 1, 2016
Primary Completion Date
December 1, 2020
Completion Date
December 1, 2020
Last Updated
January 3, 2019
NCT05006716
NCT06026319
NCT07368270
NCT07255963
NCT05940272
NCT06352242
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions